17-AAG sensitized malignant glioma cells to death-receptor mediated apoptosis

17-AAG sensitized malignant glioma cells to death-receptor mediated apoptosis

17-AAG is a selective HSP90-inhibitor that exhibited therapeutic activity in cancer. In this study three glioblastoma cell lines (U87, LN229 and U251) were treated with 17-AAG, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) or the combination of both. Treatment with subtoxic doses o...

Full description

Bibliographic Details
Main Authors: Markus David Siegelin, Antje Habel, Timo Gaiser
Format: Article
Language:English
Published: Elsevier 2009-02-01
Series:Neurobiology of Disease
Subjects:
Glioma
TRAIL/Apo2L
Survivin
HSP90
17-AAG
Proteasome
Online Access:http://www.sciencedirect.com/science/article/pii/S096999610800260X

Similar Items

Similar Items